Latest Governance News

Peak Rare Earths Limited has made significant strides in developing its Ngualla Rare Earth Project, completing an $8.5 million capital raise and progressing key negotiations with Shenghe Resources. Community initiatives and asset sales further underpin its growth strategy.

First Lithium Limited reports promising metallurgical testwork results and an imminent maiden Mineral Resource Estimate, underpinning its Mali lithium projects amid ongoing license renewal progress.

DigitalX Limited reported a 15% revenue increase in Q4 2024, driven by staking activities and performance fees, alongside a $10.3 million private placement and strategic Solana investment. The DigitalX Bitcoin ETF surpassed $50 million in funds under management, delivering a 67.4% quarterly return.

Reedy Lagoon Corporation reports promising soil sampling results at its Burracoppin Gold project while seeking partners for its iron venture amid challenging market conditions.

Red Metal Limited's December 2024 quarterly report reveals a landmark rare earth discovery at its Sybella Project, alongside advancing multiple base metals and gold targets across Australia. The company is progressing towards a mine scoping study while preparing for further drilling and metallurgical testing in 2025.

BCAL Diagnostics is poised to launch its innovative BREASTEST® breast cancer diagnostic test in early 2025, backed by recent NATA accreditation, patent acceptance, and a $2.6 million R&D tax offset.

KGL Resources has reported a significant 17.4% increase in its Jervois Mineral Resource Estimate, supported by strong drilling results, while navigating a leadership change with its CEO stepping down.

Northern Minerals reports a 15% increase in its Wolverine Deposit resource and secures $28 million in funding, advancing its Browns Range heavy rare earths project amid ongoing feasibility studies.

Tartana Minerals reports robust copper sulphate sales and completes a significant acquisition, positioning itself as a leading explorer and developer in Far North Queensland.

Northern Minerals Limited reported a $7.56 million net cash outflow from operating activities in the December 2024 quarter, offset by $28.5 million raised through borrowings, leaving a healthy cash balance of $35.76 million.

Prescient Therapeutics has secured FDA clearance to initiate its Phase 2 PTX-100 trial for relapsed cutaneous T-cell lymphoma, alongside progress in its cell therapy platforms and a solid cash position bolstered by a recent R&D rebate.

Akora Resources reports strong progress at its Bekisopa Iron Ore Project in Madagascar, highlighted by successful drilling results, completion of key technical studies, and official support from the Malagasy government. The company is on track to deliver a Pre-Feasibility Study by Q1 2025, aiming to produce high-grade direct shipping ore for steelmakers focused on decarbonisation.